In Park

Title: In Park: Innovator in Colonic Drug Delivery

Introduction

In Park is a notable inventor based in Taejon-si, South Korea. She has made significant contributions to the field of pharmaceutical sciences, particularly in the area of drug delivery systems. Her innovative work focuses on enhancing the effectiveness of colonic drug delivery through the use of polysaccharides.

Latest Patents

In Park holds a patent for a composition and pharmaceutical dosage form for colonic drug delivery using polysaccharides. This patent describes a colonic drug delivery composition that includes a first polysaccharide and a second polysaccharide, both of which are degradable by colonic enzymes. The composition is mixed at an environmental pH of about 7 or above, without the use of a cross-linking agent. The colon-selective pharmaceutical composition and dosage form are designed for the oral delivery of a drug, diagnostic reagent, or a mixture thereof, ensuring effective treatment options for patients.

Career Highlights

In Park is associated with Samyang Corporation, where she continues to advance her research and development efforts. Her work has been instrumental in creating innovative solutions for drug delivery, which can significantly improve patient outcomes.

Collaborations

In her professional journey, In Park has collaborated with esteemed colleagues such as Seung Seo Lee and Chang Baeg Lim. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical field.

Conclusion

In Park's contributions to colonic drug delivery systems exemplify her dedication to improving healthcare through innovation. Her patent and ongoing work at Samyang Corporation highlight her role as a leading inventor in the pharmaceutical industry.